Rabiei et al. (2018) reported that synbiotic supplementation led to reduced appetite following an increase in levels of peptide YY (PYY) and glucagon‐like peptide‐1 (GLP‐1) hormones in patients with MetS. Here, PYY is linked to metabolic syndrome.